Cellular and Molecular Mechanisms of Retinal Ganglion Cell Death in Hypoxic-Ischemic Injuries

Journal Title: Journal of Neurology and Experimental Neuroscience - Year 2015, Vol 1, Issue 1

Abstract

Loss of retinal ganglion cells (RGCs) occurs in retinal degenerative diseases, such as glaucoma, age-related macular degeneration, diabetic retinopathy, central retinal artery occlusion and ischemic central retinal vein thrombosis in adults and in retinopathy of prematurity in infants. A critical role of hypoxia, which underlies most of the above disorders, has been reported in causing RGC death. Disruption of blood-retinal barrier (BRB) occurs due to increased production of vascular endothelial growth factor and nitric oxide in response to hypoxia resulting in extravasation of serum derived substances and retinal edema and this may be one of important factors mediating RGC death. Activation of microglial cells in response to hypoxia and subsequent increased release of proinflammatory cytokines by them such as tumor-necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) target the TNF-receptor 1 and IL-receptor 1 on RGCs. Excess release of glutamate in retinal tissue under hypoxia activates the ionotropic glutamate receptors causing excitotoxicity through increased influx of calcium into the RGCs. Increased production of TNF-α, IL-1β and enhanced intracellular calcium results in RGC death through activating several pathways such as caspase signaling, mitochondrial dysfunction and oxidative stress. In our investigations, melatonin, an antioxidant, was shown to reduce RGC death in the adult and neonatal hypoxic retina, through suppression of TNF-α, IL-1β and glutamate levels as well as oxidative stress. Moreover, the function and structure of BRB was well preserved in these animals along with reduction in retinal edema. In view of our observations, we suggest that melatonin could be considered as a therapeutic agent to reduce RGC death in various retinal pathologies, in addition to other potential drugs/molecules of therapeutic interest that could render protection to RGCs. However, future in-depth research on the effects of melatonin on the retina under hypoxic conditions needs to be undertaken to explore its full potential in preventing/ameliorating RGC death.

Authors and Affiliations

Keywords

Related Articles

Acute Cocaine Exposure and Cerebrovascular Diseases: A Retrospective Clinical Study and Literature Review

Objective: To evaluate cocaine as a risk factor for Cerebrovascular Diseases (CVD). Introduction: Illicit substance consumption is an independent risk factor for CVD, however studies on such substances, particularly coca...

Indomethacin-Responsive Headaches in Pediatric Age: Nosographic Aspects and Limitations on the use of Indomethacin in Pediatric Population

Headaches are a common problem in children and adolescents. Indomethacinresponsive headaches are a poorly known and rare group of primary headaches, with few cases during childhood. These include a heterogeneous group of...

Report on the Third Neurological Disorders Summit (NDS-2017)

The 3rd Neurological Disorders Summit (NDS-2017) organized by United Scientific Group was held from July 7, 2017 to July 9, 2017 at Crowne Plaza Hotel, San Francisco, USA. One hundred thirty five attendees from more than...

Multidisciplinary Approach to Chronic Pelvic Pain

Chronic pelvic pain is a common medical condition affecting up to 16 percent of reproductive-aged women. There are many possible etiologies of chronic pelvic pain ranging from gynecologic to non-gynecologic. Treatment is...

Stroke Survivors: Needs, Wellness and Warning Signs in a Stroke Support Group Population

Aim: This study was designed to investigate needs of stroke survivors in stroke support groups, including their knowledge of warning signs, and the effectiveness of their care provider in acquiring rehabilitation service...

Download PDF file
  • EP ID EP223769
  • DOI 10.17756/jnen.2015-003
  • Views 147
  • Downloads 0

How To Cite

(2015). Cellular and Molecular Mechanisms of Retinal Ganglion Cell Death in Hypoxic-Ischemic Injuries. Journal of Neurology and Experimental Neuroscience, 1(1), 10-19. https://www.europub.co.uk/articles/-A-223769